膝下与膝上腔内消融治疗静脉曲张的比较
基于血管质量倡议静脉曲张登记处13731例接受膝下或膝上消融的患者,比较患者报告结局(PROs)与静脉临床严重程度评分(VCSS)。膝下治疗者术前VCSS和PROs较低,但术后评分更高、改善更少;多因素分析显示膝上治疗与更高的改善几率相关。
要点
- 膝下治疗者术前VCSS复合评分7.0±3.3低于膝上7.7±3.3(P<.001)。
- 术后膝下VCSS复合评分4.4±3.3高于膝上3.9±3.5(P<.001)。
- 膝上治疗改善VCSS的调整OR为1.31(95%CI 1.14-1.50;P<.001)。
核心结论
- 治疗区域与静脉曲张干预后PROs和VCSS复合评分显著相关。
- 术前膝下治疗者症状较轻,但术后关联反转,膝下治疗者PROs更差、VCSS复合评分更差且VCSS改善更少。
- 因此膝下干预在确保治疗后相应临床改善方面较膝上干预构成独特挑战。
研究设计与样本
- 利用血管质量倡议静脉曲张登记处识别13731例接受膝下或膝上病变静脉曲张消融的患者。
- 采用患者报告结局(PROs)和静脉临床严重程度评分(VCSS)评估结局。
- 连续变量用t检验比较,分类变量用χ2检验分析,多因素logistic回归估计干预后改善的比值比。
- 多因素模型控制年龄、性别、种族、术前VCSS复合评分和深静脉血栓史。
主要发现
- 膝下治疗者术前VCSS复合评分7.0±3.3 vs 膝上7.7±3.3(P<.001),术前PROs复合评分11.1±6.4 vs 膝上13.0±6.6(P<.001)。
- 随访时膝下治疗者术后VCSS复合评分4.4±3.3 vs 膝上3.9±3.5(P<.001),PROs复合评分6.1±4.4 vs 膝上5.8±4.5(P=.007)。
- 膝上干预者VCSS复合评分改善3.8±4.0 vs 膝下2.9±3.7(P<.001),PROs改善7.1±6.8 vs 膝下4.8±6.6(P<.001)。
- 膝上治疗改善VCSS复合评分的未调整OR为1.45(95%CI 1.28-1.65;P<.001),调整后OR为1.31(95%CI 1.14-1.50;P<.001)。
- 膝上治疗报告PROs复合评分改善的未调整OR为1.85(95%CI 1.64-2.11;P<.001),调整后OR为1.65(95%CI 1.45-1.88;P<.001)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Varicose veins have a significant impact on quality of life and can commonly occur in the thigh and calves. However, there has been no large-scale investigation examining the relationship between anatomic distribution and outcomes after varicose vein treatment. This study sought to compare below-the-knee (BTK) and above-the-knee (ATK) varicose vein treatment outcomes. METHODS: Employing the Vascular Quality Initiative Varicose Vein Registry, 13,731 patients undergoing varicose vein ablation for either BTK or ATK lesions were identified. Outcomes were assessed using patient-reported outcomes (PROs) and the Venous Clinical Severity Score (VCSS). Continuous variables were compared using the t-test, and categorical variables were analyzed using the χ2 test. Multivariable logistic regression was used to estimate the odds of improvement after intervention. The multivariable model controlled for age, gender, race, preoperative VCSS composite score, and history of deep vein thrombosis. RESULTS: Patients who received below-knee treatment had a lower preoperative VCSS composite (7.0 ± 3.3 vs 7.7 ± 3.3; P < .001) and lower PROs composite scores (11.1 ± 6.4 vs 13.0 ± 6.6; P < .001) compared with those of patients receiving above-knee treatment. However, on follow-up, patients receiving below-knee intervention had a higher postoperative VCSS composite score (4.4 ± 3.3 vs 3.9 ± 3.5; P < .001) and PROs composite score (6.1 ± 4.4 vs 5.8 ± 4.5; P = .007), the latter approaching statistical significance. Patients receiving above-knee interventions also demonstrated more improvement in both composite VCSS (3.8 ± 4.0 vs 2.9 ± 3.7; P < .001) and PROs (7.1 ± 6.8 vs 4.8 ± 6.6; P < .001). Multivariable logistic regression analysis similarly revealed that patients receiving above-knee treatment had significantly higher odds of improvement in VCSS composite in both the unadjusted (odds ratio [OR], 1.45; 95% confidence interval [CI], 1.28-1.65; P < .001 and adjusted (OR, 1.31; 95% CI, 1.14-1.50; P < .001) models. Patients receiving above-knee treatment also had a significantly higher odds of reporting improvement in PROs composite in both the unadjusted (OR, 1.85; 95% CI, 1.64-2.11; P < .001) and adjusted (OR, 1.65; 95% CI, 1.45-1.88; P < .001) models. CONCLUSIONS: Treatment region has a significant association with PROs and VCSS composite scores after varicose vein interventions. Preoperatively, there were significant differences in the composite scores of VCSS and PROs with patients receiving BTK treatment exhibiting less severe symptoms. Yet, the association appeared to reverse postoperatively, with those receiving BTK treatments exhibiting worse PROs, worse VCSS composites scores, and less improvement in VCSS composite scores. Therefore, BTK interventions pose a unique challenge compared with ATK interventions in ensuring commensurate clinical improvement after treatment.
引用
- Bai H, Gokani V, Storch JB, et al. A comparison of below-knee vs above-knee endovenous ablation of varicose veins. J Vasc Surg Venous Lymphat Disord. 2023. PMID: 37708939. doi:10.1016/j.jvsv.2023.08.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。